How N.J. can help ensure U.S. stays ahead of China in medical innovation
- gpuckrein
- Dec 15, 2025
- 1 min read
By: Debbie Hart, CEO, BioNJ and Dan Leonard, Executive Director, We Work For Health
Will the epicenter of global medical innovation be in New Jersey or Shanghai?
That is a critical question before U.S. policymakers right now, and the stakes arguably couldn’t be higher. How the country fends off China’s rising biopharma sector affects everything from our health and national security to local, state and national economies.
Today, the U.S. leads the world in biopharmaceutical innovation. No industry has answered the call to “build here” more enthusiastically than the life sciences. Companies are developing cutting-edge medicines while investing hundreds of billions of dollars to build, expand and modernize factories and research facilities.